Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network. [electronic resource]
Producer: 19930330Description: 533-7 p. digitalISSN:- 0022-1899
- AIDS Vaccines -- immunology
- Amino Acid Sequence
- Binding, Competitive
- Blotting, Western
- CD4-Positive T-Lymphocytes -- immunology
- Enzyme-Linked Immunosorbent Assay
- Gene Products, env -- biosynthesis
- HIV Antibodies -- biosynthesis
- HIV Envelope Protein gp120 -- immunology
- HIV Envelope Protein gp160
- HIV Envelope Protein gp41 -- immunology
- HIV Infections -- immunology
- HIV-1 -- immunology
- Humans
- Immunization, Secondary
- Molecular Sequence Data
- Neutralization Tests
- Peptide Fragments -- immunology
- Protein Precursors -- biosynthesis
- Recombinant Proteins -- immunology
- Time Factors
- Vaccinia virus -- immunology
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.